Exposure to Novel Agents Contribute to Extramedullary Spread of Multiple Myeloma Cells and Altered Expression of Adhesion Molecules: A Clinicopathologic Study of 91 Consecutive Autopsy Cases

• Published in: Blood Vol. 120; no. 21; p. 1832
• Main Authors: Mine, Sohtaro, Hagiwara, Shotaro, Tagashira, Amane, Igari, Toru, Miwa, Akiyoshi
• Format: Journal Article
• Language: English; Japanese
• Published: Elsevier Inc 16.11.2012; American Society of Hematology

Abstract 1832 Recent development of novel agents such as bortezomib, lenalidomide, and thalidomide improved the remission rate and survival of multiple myeloma. However, the end stage of myeloma is still uncontrollable. The extramedullary disease (EMD) progression of myeloma was frequently observed...